Effect of Curcumin on Apoptosis and Proliferation of Human Hepatocellular Carcinoma WCH-17 Cell Line
Hepatocellular carcinoma (HCC) is the most common cancer of the liver and the 5th commonest malignancy and also the third leading cause of cancer related death worldwide. Herbal medicines have an important role to prevent cancer. Curcumin is the herbal and dietary spice turmeric with diverse pharmacologic effects including antiproliferative, antiangiogenic and anti-cancer properties. The aim of the present study was to analyze the effect of curcumin on cell growth and apoptosis in the hepatocellular carcinoma WCH-17 cell line. Materials and Methods: MTT assay and flow cytometry assay were used to evaluate proliferative and apoptotic effect of curcumin on WCH-17 cell line. Results: curcumin inhibited the growth of WCH-17 cell and induced apoptosis significantly with a time- and dose-dependent manner. Discussion: Our finding clearly indicated that curcumin has a significant inhibitory and apoptotic effect. Conclusion: curcumin can significantly inhibit the growth of WCH-17 cell and play a significant role in apoptosis.
World Health Organization. Mortality database. Available from: URL: http://www.who.int/whosis/en
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841
Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y
Acad Sci 2002; 963: 13-20
Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143-154
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
Yeh CT, Chen TC, Chang ML, Hsu CW, Yeh TS, Lee WC, Huang SF, Tsai CC. Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol 2007; 79: 92-96
Simon D Taylor-Robinson. Hepatocellular carcinoma: Epidemiology, risk factors and Pathogenesis. World J Gastroenterol. 2008; 14(27): 4300-4308
Mimi C. Yua, Jian-Min Yuan. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004; 175 (5): 72-78
Temple, N. J. Antioxidants and disease: more questions than answers. Nutr. Res. 2000; 20: 449–459.
Willett, W. C. Diet and health: what should we eat. Science. 1994; 254: 532–537.
Willett, W. C. Balancing life-style and genomics research for disease prevention. Science. 2002; 296: 695–698.
Wargovich, M. J. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis. 1987; 8: 487–489.
Wargovich, M. J., Woods, C. J., Eng, V. W., Stephens, L. C. & Gray, K. Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res. 1988; 48: 6872–6875.
R.A. Sharma, A.J. Gescher, W.P. Steward. Curcumin: The story so far. European Journal of Cancer. 2005; 41 (13): 1955–196815
Preetha Anand, Ajaikumar B. Kunnumakkara, et al. Bioavailability of Curcumin: Problems and Promises. Mol. Pharmaceutics, 2007; 4 (6): 807–818
Lao, C.D.; Ruffin, M.T. IV.; Normolle, D.; et al. Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 2006, 6, 10-17.
Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa). J. Altern. Complement. Med. 2003, 9, 161–168.
Cheng, A.L.; Hsu, C.H.; Lin, J.K.; et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001, 21, 2895–2900.
Sharma, R.A.; Euden, S.A.; Platton, S.L.; et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004, 10, 6847–6854.
Sharma, R.A.; McLelland, H.R.; Hill, K.A.; et al. harmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001, 7, 1894–1900.
Mou-Tuan Huang, Robert C. Smart, Ching-Quo Wong. Inhibitory Effect of Curcumin, Chlorogenic Acid, Caffeic Acid, and Ferulic Acid on Tumor Promotion in Mouse Skin by 12-O-Tetradecanoylphorbol-13-acetate. Cancer Res. 1988; 48, 5941-5946.
Kawamori, T., Lubet, R., Steele, V.E., et al. Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer. Cancer Res. 1999; 59, 597-601.
Liu, J.Y., Lin, S.J. and Lin, S.KCarcinogenesis. 1993; 14, 857-861.
Pal, S., Choudhuri, T., Chattopadhyay, S., et al. Mechanisms of Curcumin-Induced Apoptosis of Ehrlich's Ascites Carcinoma Cells. Biochem. Biophys. Res. Commun. 2001; 288, 658-665.
Jee, S.H., Shen, S.C., Tseng, C.R., et al. Curcumin induces a P53 dependent-apoptosis in basal cell carcinoma cell. J. Invest. Dermatol. 1988; 111, 656-661.
Chun-Yuan, Yi-Hsiang Lin and Chin-Cheng Su. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. International journal of molecular medicine. 2010; 26: 673-678, 2010
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: an ‘old-age’ disease with an ‘age-old’ solution. Cancer Lett. 2008; 267: 133-164
Yeh TC, Chiang PC, Li TK, Hsu JL, et al. Genistein induces apoptosis in human
hepatocellar carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol 2007; 73: 782-792
Mukherjee N, Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Dey S and Roy M: Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem. 2007; 297: 31-39
Lu HF, Lai KC, Hsu SC, Lin HJ, Yang MD, Chen YL, Fan MJ, Yang JS, Cheng PY, Kuo CL and Chung JG: Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina
ganglion cells. Oncol Rep. 2009; 22: 97-104,
Lin L.-I., Ke Y.-F., Ko Y.-C et al. Curcumin Inhibits SK-Hep-1 Hepatocellular Carcinoma Cell Invasion in vitro and Suppresses Matrix Metalloproteinase-9 Secretion. Oncology 1998; 55: 349–353
Katelyn Austin Hanson and Nancy Hopkins. The Inhibitory Effects of Curcumin and Coumarin Analogues on the NF-kB Pathway in Heptocellular Carcinoma The FASEB Journal. . 2012; 26 (1): 797-806
Zheng-Cai Liu, Zhao-Xu Yang, Jing-Shi Zhou et al. Curcumin regulates hepatoma cell proliferation and apoptosis through the Notch signaling pathway.
Int J Clin Exp Med 2014; 7(3):714-718
Geissler K, Zach O. Pathways involved in Dro¬sophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Tritho¬rax pathway. Ann Hematol 2012; 91: 645-669.
Hu YY, Zheng MH, Zhang R, Liang YM, Han H. Notch signaling pathway and cancer metasta¬sis. Adv Exp Med Biol 2012; 727: 186-198.
Han JX, Hendzel MJ, Allalunis-Turner J. Notch signaling as a therapeutic target for breast cancer treatment? Breast Cancer Res 2011; 13: 210.
Li DW, Wu Q, Peng ZH, Yang ZR, Wang Y. Ex¬pression and significance of Notch1 and PTEN in gastric cancer. Ai Zheng 2007; 26: 1183-1187.
Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, an¬giogenesis and metastasis of different can¬cers through interaction with multiple cell sig¬naling proteins. Cancer Lett 2008; 269: 199-225
Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, Aggarwal BB. Multitargeting by curcumin as revealed by molecular interac¬tion studies. Nat Prod Rep 2011; 28: 1937-1955.
Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofac¬tors 2013; 39: 27-36.
Mukhopadhyay A, Banerjee S, Stafford LJ, et al. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene. 2002; 21, 8852-61.
Ahn JC, Kang JW, Shin JI, Chung P.S. Combination treatment with photodynamic therapy and curcumin induces mitochondria-dependent apoptosis in AMC-HN3 cells. Int J Oncol. 2012; 41, 2184-90.
Shakibaei M, Mobasheri A, Lueders C, et al. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-kappaB and Src protein kinase signaling pathways. PLoS One, 2013; 8, e57218
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright ©2022 Academic Journals Center
To make sure that you can receive messages from us, please add the 'academicjournalscenter.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.